NEO – Neogenomics Inc.
Float Short %
4.01
Margin Of Safety %
Put/Call OI Ratio
0.33
EPS Next Q Diff
0.11
EPS Last/This Y
0.72
EPS This/Next Y
0.1
Price
6.61
Target Price
8.1
Analyst Recom
2.33
Performance Q
-9.27
Relative Volume
0.83
Beta
1.55
Ticker: NEO
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-07-25 | NEO | 6.29 | 0.28 | 0.07 | 19567 |
2025-07-28 | NEO | 6.47 | 0.28 | 0.15 | 19633 |
2025-07-29 | NEO | 5.26 | 0.27 | 0.58 | 20602 |
2025-07-30 | NEO | 5.09 | 0.28 | 0.04 | 25573 |
2025-07-31 | NEO | 4.84 | 0.26 | 0.12 | 25695 |
2025-08-01 | NEO | 5.17 | 0.26 | 0.94 | 25902 |
2025-08-04 | NEO | 5.67 | 0.32 | 2.76 | 26096 |
2025-08-05 | NEO | 5.62 | 0.31 | 0.01 | 25598 |
2025-08-06 | NEO | 5.5 | 0.31 | 0.00 | 25547 |
2025-08-07 | NEO | 5.77 | 0.30 | 0.02 | 26323 |
2025-08-08 | NEO | 5.8 | 0.30 | 0.05 | 26284 |
2025-08-11 | NEO | 5.84 | 0.30 | 0.10 | 26297 |
2025-08-12 | NEO | 6.09 | 0.30 | 0.72 | 26296 |
2025-08-13 | NEO | 6.24 | 0.30 | 0.01 | 26354 |
2025-08-14 | NEO | 6.18 | 0.30 | 0.07 | 26226 |
2025-08-15 | NEO | 6.2 | 0.30 | 0.00 | 26220 |
2025-08-18 | NEO | 6.24 | 0.33 | 0.17 | 19343 |
2025-08-19 | NEO | 6.31 | 0.33 | 0.00 | 19388 |
2025-08-20 | NEO | 6.09 | 0.33 | 0.01 | 19510 |
2025-08-21 | NEO | 6.18 | 0.33 | 0.06 | 19652 |
2025-08-22 | NEO | 6.61 | 0.33 | 0.05 | 19678 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-07-25 | NEO | 6.29 | -15.4 | - | 0.16 |
2025-07-28 | NEO | 6.47 | -17.9 | - | 0.16 |
2025-07-29 | NEO | 5.25 | -17.9 | - | 0.16 |
2025-07-30 | NEO | 5.10 | -17.9 | - | 0.16 |
2025-07-31 | NEO | 4.84 | -17.9 | - | 0.16 |
2025-08-01 | NEO | 5.16 | -43.1 | - | 0.11 |
2025-08-04 | NEO | 5.67 | -43.1 | - | 0.11 |
2025-08-05 | NEO | 5.62 | -43.1 | - | 0.11 |
2025-08-06 | NEO | 5.49 | -43.1 | - | 0.11 |
2025-08-07 | NEO | 5.76 | -43.1 | - | 0.11 |
2025-08-08 | NEO | 5.80 | -43.1 | - | 0.10 |
2025-08-11 | NEO | 5.83 | -52.3 | - | 0.10 |
2025-08-12 | NEO | 6.09 | -52.3 | - | 0.10 |
2025-08-13 | NEO | 6.24 | -52.3 | - | 0.10 |
2025-08-14 | NEO | 6.18 | -52.3 | - | 0.10 |
2025-08-15 | NEO | 6.20 | -52.3 | - | 0.10 |
2025-08-18 | NEO | 6.24 | -52.3 | - | 0.10 |
2025-08-19 | NEO | 6.31 | -52.3 | - | 0.10 |
2025-08-20 | NEO | 6.09 | -52.3 | - | 0.10 |
2025-08-21 | NEO | 6.18 | -52.3 | - | 0.10 |
2025-08-22 | NEO | 6.61 | -52.3 | - | 0.10 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-07-25 | NEO | 4.42 | 2.78 | 3.37 |
2025-07-28 | NEO | 4.42 | -4.13 | 3.37 |
2025-07-29 | NEO | 4.42 | -4.13 | 3.37 |
2025-07-30 | NEO | 4.42 | -4.13 | 3.37 |
2025-07-31 | NEO | 4.42 | -4.13 | 3.37 |
2025-08-01 | NEO | 4.40 | -4.13 | 3.35 |
2025-08-04 | NEO | 4.40 | -4.08 | 3.35 |
2025-08-05 | NEO | 4.40 | -4.08 | 3.35 |
2025-08-06 | NEO | 6.77 | -4.08 | 3.35 |
2025-08-07 | NEO | 6.52 | -4.08 | 3.36 |
2025-08-08 | NEO | 6.52 | -4.08 | 3.36 |
2025-08-11 | NEO | 6.52 | -4.08 | 3.35 |
2025-08-12 | NEO | 7.04 | -4.08 | 3.94 |
2025-08-13 | NEO | 7.04 | -4.08 | 3.94 |
2025-08-14 | NEO | 7.04 | -4.08 | 3.94 |
2025-08-15 | NEO | 7.04 | -4.08 | 3.94 |
2025-08-18 | NEO | 7.04 | -2.31 | 3.94 |
2025-08-19 | NEO | 7.04 | -2.31 | 4.01 |
2025-08-20 | NEO | 2.99 | -2.31 | 4.01 |
2025-08-21 | NEO | 2.99 | -2.31 | 4.01 |
2025-08-22 | NEO | 2.82 | -2.31 | 4.01 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.06
Avg. EPS Est. Current Quarter
0.02
Avg. EPS Est. Next Quarter
0.05
Insider Transactions
2.82
Institutional Transactions
-2.31
Beta
1.55
Average Sales Estimate Current Quarter
183
Average Sales Estimate Next Quarter
189
Fair Value
Quality Score
42
Growth Score
45
Sentiment Score
30
Actual DrawDown %
89.3
Max Drawdown 5-Year %
-91.9
Target Price
8.1
P/E
Forward P/E
36.69
PEG
P/S
1.24
P/B
1
P/Free Cash Flow
EPS
-0.82
Average EPS Est. Cur. Y
0.1
EPS Next Y. (Est.)
0.2
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-15.1
Relative Volume
0.83
Return on Equity vs Sector %
-36.9
Return on Equity vs Industry %
-22.9
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.06
EBIT Estimation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2200
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading